Genetic loss of SH2B3 in acute lymphoblastic leukemia Journal Article


Authors: Perez-Garcia, A.; Ambesi-Impiombato, A.; Hadler, M.; Rigo, I.; LeDuc, C. A.; Kelly, K.; Jalas, C.; Paietta, E.; Racevskis, J.; Rowe, J. M.; Tallman, M. S.; Paganin, M.; Basso, G.; Tong, W.; Chung, W. K.; Ferrando, A. A.
Article Title: Genetic loss of SH2B3 in acute lymphoblastic leukemia
Abstract: The SH2B adaptor protein 3 (SH2B3) gene encodes a negative regulator of cytokine signaling with a critical role in the homeostasis of hematopoietic stem cells and lymphoid progenitors. Here, we report the identification of germline homozygous SH2B3 mutations in 2 siblings affected with developmental delay and autoimmunity, one in whom B-precursor acute lymphoblastic leukemia (ALL) developed. Mechanistically, loss of SH2B3 increases Janus kinase-signal transducer and activator of transcription signaling, promotes lymphoid cell proliferation, and accelerates leukemia development in a mouse model of NOTCH1-induced ALL. Moreover, extended mutation analysis showed homozygous somatic mutations in SH2B3 in 2 of 167 ALLs analyzed. Overall, these results demonstrate a Knudson tumor suppressor role for SH2B3 in the pathogenesis of ALL and highlight a possible link between genetic predisposition factors in the pathogenesis of autoimmunity and leukemogenesis.
Keywords: risk; self-renewal; hematopoietic stem-cells; variants; deficient mice; signal-transduction; myeloproliferative neoplasms; of-function mutations; b-progenitor; adapter protein lnk
Journal Title: Blood
Volume: 122
Issue: 14
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2013-10-03
Start Page: 2425
End Page: 2432
Language: English
ACCESSION: WOS:000326078200025
DOI: 10.1182/blood-2013-05-500850
PROVIDER: wos
PMCID: PMC3790510
PUBMED: 23908464
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman